Latest News


GlaxoSmithKline pulls application for new drug use

Charlotte Observer (N.C.), The | 7 hours 33 minutes ago

TRENTON, N.J. British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. ... (more)


Pharmasset: hepatitis C drug trial will continue

Fort Worth Star-Telegram (Texas) | 7 hours 34 minutes ago

The Associated Press NEW YORK ? Pharmasset Inc. said Monday that it will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C.... (more)


Light Reading - VOIP - AT&T Helps Cerner - Telecom News Wire

Light Reading | 7 hours 34 minutes ago

DALLAS -- Connecting associates around the world and collaborating with clients is now a quicker, more interactive process for global healthcare solutions provider Cerner (Nasdaq: CERN). Cerner began using the AT&T* Telepresence Solution, an immersive video technology that connects remote participants, earlier this year to help respond to client service requests in a timely manner and to conduct virtual business meetings with its associates, clients and business partners around the world.... (more)


Earnings Preview: Medtronic

Philadelphia Inquirer, The | 7 hours 38 minutes ago

WASHINGTON - Medtronic, the world's largest medical device maker, reports earnings for the second fiscal quarter of 2010 on Tuesday. The following is a summary of key developments and analyst opinion for the last period.... (more)


Britain's GlaxoSmithKline pulls application to sell enlarged prostate drug for blocking cancer

Sun (Baltimore), The | 7 hours 41 minutes ago

British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. approval of a drug to prevent prostate cancer.... (more)


Spray can prevent premature ejaculation: study

Yahoo! | 7 hours 42 minutes ago

WASHINGTON (Reuters) ? A spray that numbs the penis can help prevent premature ejaculation, doctors reported on Thursday, and drug maker Sciele Pharma Inc, a division of Japan's Shionogi, plans to file for U.S. approval next year.... (more)


Pharmasset says Roche will continue enrolling subjects in RG7128 trial after committee review

Hartford Courant (Conn.), The | 8 hours 5 minutes ago

Pharmasset Inc. said Monday that it will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C.... (more)


Rigel shares rise on RBC analyst upgrade

Seattle Times, The | 8 hours 22 minutes ago

Rigel Pharmaceuticals Inc. rose after an RBC Capital Markets analyst recommended buying shares of the drug developer based on his expectations the company will announce news of a partnership for a key drug candidate.... (more)




 1  2  3  4  5  6  7  8  9 ...   Next >

406 Stories  |   RSS Feed



Sign up for AANP SmartBrief



Designed specifically for nurse practitioners and health care professionals like you, AANP SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important health care issues. Learn more

Latest Blog Postsview more


Companies in the news